AKT1 and neoplasm: Beyond chemoresistance, ATAD2 contributes to tumor progression and immune evasion; for instance, in papillary thyroid cancer (PTC), it promotes oncogenic behaviors by activating the PI3K-AKT pathway and regulating the G1/S cell cycle transition [129].